Home » Authors » Omar Ford

Articles by Omar Ford

Deals roundup: Boston Sci sells most of its private portfolio for $140M

June 20, 2008

IBM says hope for healthcare lies in EHRs and prevention

June 13, 2008

Study shows BSGI to be better for cancer detection

June 12, 2008

Cook continues launch of new devices in competitive sectors

June 12, 2008

Diabetes test gives 5-year disease-prediction window

June 12, 2008

Study shows BSGI to be better for cancer detection

June 11, 2008

After EVEREST stumble, firm pushes ahead on PROSPECT

June 10, 2008

Diabetes test gives 5-year disease-prediction window

June 9, 2008

BD unveils updated version of Bactec Blood Culture System

June 5, 2008

PTG bought by Royal DSM, unveils antimicrobial solution

May 30, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...